Nathan Lighthizer, OD, FAAO
Born and raised in Bismarck, ND, Nate Lighthizer, OD, FAAO, is a graduate of Pacific University College of Optometry. Upon graduation, he completed a residency in Family Practice Optometry with an emphasis in Ocular Disease through Northeastern State University Oklahoma College of Optometry. Dr. Lighthizer has since joined the faculty at the Oklahoma College of Optometry and serves as the Chief of Specialty Care Clinics and the Chief of Electrodiagnostics Clinic.
In 2014, he founded and now heads the Dry Eye Clinic at the College of Optometry. Also in 2014, he was named the Director of Continuing Education as well as the Assistant Dean for Clinical Care Services at the Oklahoma College of Optometry. He is a founding member, and currently serves as Vice President, of the Intrepid Eye Society which is a group of emerging thought leaders in optometry. He was named a member of PCON 250—a list of the top 250 optometrists in the country who practice progressively, provide innovative patient care, conduct optometric research or excel in academia and share what they have learned with other optometrists to advance the profession.
Dr. Lighthizer lectures nationally on numerous topics, most notably advanced ophthalmic procedures, electrodiagnostics, and ocular disease.
4
It’s Time to Flip Your Dry Eye Protocol
Kick off 2024 by learning how to flip your dry eye disease (DED) protocol and adopt interventional approaches to effectively address the root causes of DED.
Understanding New Research on Cytokine Levels in Tears of Dry Eye Patients
Join Damon Dierker, OD, FAAO, and Nathan Lighthizer, OD, FAAO, to review the findings from a study on cytokine levels in the tears of dry eye patients.
iCare USA—Unique Technology Live with Lighthizer
In this session from Eyes On Glaucoma 2022, Nathan Lighthizer, OD, FAAO discusses how iCare USA's technology is helping establish the next level of eyecare.
Living the Laser Life: The OD and MD Perspective
In this talk from Eyes on Glaucoma 2022, Dr. Paul Singh and Dr. Nathan Lighthizer review the clinical evidence and share their case experience regarding SLT as a first-line treatment for open angle glaucoma.